These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8988695)

  • 1. Counselling implications of chromosomal abnormalities other than trisomy 21 detected through a maternal serum screening programme.
    Sheridan E; Williams J; Caine A; Morgan R; Mason G; Mueller RF
    Br J Obstet Gynaecol; 1997 Jan; 104(1):42-5. PubMed ID: 8988695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.
    Zhu Y; Lu S; Bian X; Wang H; Zhu B; Wang H; Xu Z; Xu L; Yan W; Zeng Y; Chen Z; Tang S; Shen G; Miao Z
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):379-84. PubMed ID: 27343319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
    Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
    Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis of chromosome abnormalities and nine microdeletion syndromes using both traditional karyotyping and BoBs].
    Tang XH; Yang BC; Zhu S; Su J; Zhang JM; Yin YF; Feng Y; Li DM; Zhao QF; Yu R; Zhu BS
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):325-30. PubMed ID: 27256438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triploid pregnancy detected incidentally by Down's syndrome screening.
    Hanning I; Mires GJ
    Ann Clin Biochem; 2002 Mar; 39(Pt 2):157-9. PubMed ID: 11928766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
    Han SH; An JW; Jeong GY; Yoon HR; Lee A; Yang YH; Lee KP; Lee KR
    Korean J Lab Med; 2008 Oct; 28(5):378-85. PubMed ID: 18971619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study.
    Nishiyama M; Sekizawa A; Ogawa K; Sawai H; Nakamura H; Samura O; Suzumori N; Nakayama S; Yamada T; Ogawa M; Katagiri Y; Murotsuki J; Okamoto Y; Namba A; Hamanoue H; Ogawa M; Miura K; Izumi S; Kamei Y; Sago H
    Prenat Diagn; 2016 Dec; 36(12):1121-1126. PubMed ID: 27760457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis of women with an adverse reproductive history using both traditional karyotyping and SNP-array].
    Yu HS; Guo H; Shen SS; Li XC; Zhang LP; Fan XF
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):155-159. PubMed ID: 29609228
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.